Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
IMCC-Based Elucidation on Divergent and Convergent of Inter-Module Coordination Maps the Pharmacological Puzzle of Natural Products on Cerebral Ischemia
122 Pages Posted: 21 Dec 2018
More...Abstract
Detecting the strength of inter-module coordination and modular rewiring is essential to characterize the reactive bio-systematical variation of different related drugs, especially for multiple-target compounds from traditional Chinese medicine (TCM). However, the quantitative method for inter-module connections is far from perfect. Here, an evaluation approach (named as IMCC) for inter-module coordination and its transition was developed. Applying IMCC to mouse ischemia-related genes micro-array, we investigated modular map and its rewiring from disease to drugs perturbation states: transition of IMCC distribution from vehicle to negative-phenotype group (CM) was minor than that to other positive-phenotype groups (BA, JA, or UA). Furthermore, the architecture in cerebral ischemia exhibited a characteristic "core-periphery structure", highlighting "core" as nervous injury related pathways bridged by MAPK signaling pathway. Notably, this architecture was rewired by the positive-phenotype compounds heterogeneously: BA and UA converged modules into an intensively connected integrity; whereas JA diverged partial modules and widened the remaining inter-module paths. Combination of compounds with divergent directions showed a merging or fusing mode. The conclusion was validated by in vivo experiments. This strategy may lead to systematically explore detailed variation of inter-module pharmacological action mode of multiple-target drugs and combination therapies.
Funding Statement: This work was supported by National Science and Technology Major Projects “Major New Drug Development Project”. [grant number 2017ZX09301-059].
Declaration of Interests: The authors declare that they have no competing interests.
Ethics Approval Statement: All of the animal experiments were conducted in accordance with the Prevention of Cruelty to Animals Act 1986 and NIH Guidelines for the Care and Use of Laboratory Animals for Experimental Procedures [Council, 1996], and also approved by Ethics Committee of China Academy of Chinese Medicine.
Keywords: IMCC, inter-module coordination, multiple-target compounds, cerebral ischemia
Suggested Citation: Suggested Citation